Canadian Natural Resources Ltd <CNQ.TO>: Jefferies raises target price to C$70 from C$64
CNQ•Related News
Argenx Says Phase 3 Alkivia Trial Of Efgartigimod In Autoimmune Myositis Met Primary Endpoint
ARGX•
BioMarin Pharmaceutical Inc. <BMRN.O>: Piper Sandler raises target price to $88 from $82
BMRN•
Gold edges higher on softer dollar as rate-hike expectations ease
GLD•
From coffee to hotpot, brands race to grab a bite of China's growing burger market
YUMC•
Mesoblast completes dosing in Phase 3 rexlemestrocel-L trial for chronic low back pain
MESO•